Dissolution and liquidation of Chinese subsidiary Hebei Jiexi Biological Products Co., Ltd.
First written in FY2017. 10 of 13 entries say "Restated". Latest entry: FY2021.
No other company in this theme has enough history to compare yet.
- FY2021AchievedAnnual report
「Liquidation of 河北杰希生物製品有限公司 has been completed.」
The liquidation procedures for the Chinese subsidiary, whose dissolution was resolved in April 2017, were completed, and it was removed from the list of consolidated subsidiaries. - FY2021-Q1RestatedAnnual report
「Our consolidated subsidiary 河北杰希生物製品有限公司 resolved to dissolve as of 26 April 2017 and is currently undergoing liquidation procedures.」
Reconfirmed that the Chinese subsidiary remains in the process of dissolution and liquidation. No completion of the liquidation was stated. - FY2020-Q3RestatedAnnual report
「Our consolidated subsidiary 河北杰希生物製品有限公司 resolved to dissolve as of 26 April 2017 and is currently undergoing liquidation procedures.」
Reconfirmed that the Chinese subsidiary remains in the process of dissolution and liquidation. No completion of the liquidation was stated. - FY2020-Q2RestatedAnnual report
「Our consolidated subsidiary 河北杰希生物製品有限公司 resolved to dissolve as of 26 April 2017 and is currently undergoing liquidation procedures.」
Reconfirmed that the Chinese subsidiary remains in the process of dissolution and liquidation. No completion of the liquidation was stated. - FY2020-Q1RestatedAnnual report
「Our consolidated subsidiary 河北杰希生物製品有限公司 resolved to dissolve as of 26 April 2017 and is currently undergoing liquidation procedures.」
Reconfirmed that the Chinese subsidiary remains in the process of dissolution and liquidation. No completion of the liquidation was stated. - FY2019RestatedAnnual report
「河北杰希生物製品有限公司 resolved to dissolve as of 26 April 2017 and is currently undergoing liquidation procedures.」
Reconfirmed that the Chinese subsidiary remains in the process of dissolution and liquidation. No completion of the liquidation was stated. - FY2019-Q3RestatedAnnual report
「Our consolidated subsidiary 河北杰希生物製品有限公司 resolved to dissolve as of 26 April 2017 and is currently undergoing liquidation procedures.」
Reconfirmed that the Chinese subsidiary remains in the process of dissolution and liquidation. No completion of the liquidation was stated. - FY2019-Q2RestatedAnnual report
「Our consolidated subsidiary 河北杰希生物製品有限公司 resolved to dissolve as of 26 April 2017 and is currently undergoing liquidation procedures.」
Reconfirmed that the Chinese subsidiary remains in the process of dissolution and liquidation. No completion of the liquidation was stated. - FY2019-Q1RestatedAnnual report
「Our consolidated subsidiary 河北杰希生物製品有限公司 resolved to dissolve as of 26 April 2017 and is currently undergoing liquidation procedures.」
Reconfirmed that the Chinese subsidiary remains in the process of dissolution and liquidation. No completion of the liquidation was stated. - FY2018RestatedAnnual report
「河北杰希生物製品有限公司 resolved to dissolve as of 26 April 2017 and is currently undergoing liquidation procedures.」
Reconfirmed that the Chinese subsidiary is undergoing dissolution and liquidation procedures. No completion of the liquidation was stated. - FY2018-Q2AdvancedAnnual report
「At a meeting of our Board of Directors held on 26 April 2017, we resolved to dissolve and liquidate our consolidated subsidiary 河北杰希生物製品有限公司, which is currently undergoing liquidation procedures.」
Disclosed that the Chinese subsidiary is currently undergoing liquidation procedures following the resolution to dissolve and liquidate it. - FY2018-Q1RestatedAnnual report
「At a meeting of our Board of Directors held on 26 April 2017, we resolved to dissolve and liquidate our consolidated subsidiary 河北杰希生物製品有限公司.」
The resolution to dissolve and liquidate the Chinese subsidiary was reiterated in the business description. No completion or progress of the liquidation procedures was stated. - FY2017First statedAnnual report
「At a meeting of our Board of Directors held on 26 April 2017, we resolved to dissolve and liquidate our consolidated subsidiary 河北杰希生物製品有限公司.」
The Board of Directors resolved to dissolve and liquidate the Chinese consolidated subsidiary on 26 April 2017.